Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orthopedic Implants

This article was originally published in Start Up

Executive Summary

Despite a profit-squeezing market and huge established competitors, orthopedic start-ups continue to jump into the business.

You may also be interested in...

Joint Resurfacing: Boom or Bust?

One of the hottest topics at the 2007 AAOS was the the trend toward resurfacing rather than completely replacing joints damaged by arthritis and other causes. There are a variety of metallic, synthetic and biologic methods used in hip, knee, shoulder and extremity joint resurfacing, many designed for younger patients who wish to remain active and avoid total joint replacement.

Osteoimplant Technology Inc.

Orthopedic Implants. Osteoimplant offers both standard and custom, specialty orthopedic implants including hip and shoulder implants, and trauma products, including wires, pins, plates and splints.

Kinetikos Medical Inc.

Orthopedic Implants. Kinetikos develops orthopedic trauma products (bone screws) and reconstructive products such as toe and wrist implants, solely for the small bone market.

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts